NASDAQ: TELA - TELA Bio, Inc.

六个月盈利: -36.88%
部门: Healthcare

促销时间表 TELA Bio, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy.

更多详情
The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2019-11-08
ISIN US8723811084
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.telabio.com
Цена ао 5.56
每日价格变化: -0.3425% (2.92)
每周价格变化: +2.11% (2.85)
每月价格变化: -3.96% (3.03)
3个月内价格变化: +10.65% (2.63)
六个月内的价格变化: -36.88% (4.61)
每年价格变化: -56.04% (6.62)
3年内价格变化: -77.34% (12.84)
5年内价格变化: -75.23% (11.75)
10年价格变化: 0% (2.91)
年初以来价格变化: -1.02% (2.94)
所有参数

低估

姓名 意义 年级
P/S 2.55 6
P/BV 7.9 1
P/E 0 0
EV/EBITDA -3.35 0
全部的: 4.63

效率

姓名 意义 年级
ROA, % -59.79 0
ROE, % -247.15 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.9495 10
全部的: 7.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 279.56 10
盈利能力 Ebitda, % 116.13 10
盈利能力 EPS, % -86.03 0
全部的: 7
更多详情

机构 体积 分享, %
Essex Woodlands Management Inc. 4110709 16.68
Orbimed Advisors LLC. 2835542 11.5
First Light Asset Management, LLC 2554641 10.36
Nantahala Capital Management, LLC 2195732 8.91
AIGH Capital Management LLC 1377945 5.59
Blackrock Inc. 1078056 4.37
Vanguard Group Inc 998853 4.05
Pentwater Capital Management LP 990000 4.02
SILVERARC CAPITAL MANAGEMENT, LLC 795080 3.23
Federated Hermes, Inc. 712300 2.89

ETF 分享, % 本年盈利能力, % 股息, %
Jacob Forward ETF 2.05852 43.03 0.15284
iShares Micro-Cap ETF 0.01069 17.09 1.54048



导师 职称 支付 出生年份
Mr. Antony Koblish Co-founder, President, CEO & Director 1.03M 1966 (59 年)
Mr. Roberto E. Cuca J.D. CFO & COO 674.78k 1968 (57 年)
Mr. Paul Talmo Chief Technology Officer 595.67k 1972 (53 年)
Ms. Megan Smeykal VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer N/A 1976 (49 年)
Mr. D. Taylor Ocasio General Counsel & Corporate Secretary N/A
Ms. Jennifer Lou Armstrong Senior Vice President of Human Resources N/A 1970 (55 年)
Mr. Gregory A. Firestone Chief Commercial Officer N/A 1959 (66 年)
Mr. Michael Leonard Senior Vice President of Technical Operations N/A
Mr. Peter C. Murphy Chief Commercial Officer 542.34k 1973 (52 年)
Louisa Smith Investor Relations Contact Officer N/A

地址: United States, Malvern. PA, 1 Great Valley Parkway - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.telabio.com